Fibrinolysis in Degos’ Disease

Please copy the URL and add it into your RSS Feed Reader.

Facebook Linkedin Weibo

Thromb Haemost 1985; 54(03): 730
DOI: 10.1055/s-0038-1660113

Letter to the Editor

Schattauer GmbH Stuttgart

J A Páramo

¹Service of Hematology, University Clinic of Navarra, Spain

,

E Rocha

¹Service of Hematology, University Clinic of Navarra, Spain

,

B Cuesta

¹Service of Hematology, University Clinic of Navarra, Spain

,

J M Arejola

²Dept. of Internal Medicine, University Clinic of Navarra, Spain

,

M Montejo

³Hospital Cruces de Bilbao, Spain

,

J Aguirre

³Hospital Cruces de Bilbao, Spain

,

J Prieto

²Dept. of Internal Medicine, University Clinic of Navarra, Spain

,

E Rocha Hernando Dr.

Service of Hematology, University Clinic of Navarra, Avda. Pío XII s/n Apartado 192, 318080-Pamplona, Spain

Further Information

Publication History

Received 03 June 1985

Accepted 29 July 1985

Publication Date:
19 July 2018 (online)

References
1 Black MM, Nishioka K, Levene GM. The role of dermal blood vessels in the pathogenesis of malignant atrophic papulosis (Degos’ disease). A study of two cases using enzyme histochemical, fibrinolytic, electron-microscopal and immunological techniques. Br J Dermatol 1973; 88: 213-219

MissingFormLabel
Crossref PubMed Search in Google Scholar
2 Colucci M, Paramo JA, Collen D. Generation in plasma of a fast-acting inhibitor of plasminogen activator in response to endotoxin stimulation. J Clin Invest 1985; 75: 818-824

MissingFormLabel
Crossref PubMed Search in Google Scholar
3 Delaney TJ, Black MM. Effect of fibrinolytic treatment in malignant atrophic papulosis. Br Med J 1975; 3: 415

MissingFormLabel
PubMed Search in Google Scholar
4 Chmielewska J, Ranby M, Wiman B. Evidence for a rapid inhibitor to tissue plasminogen activator in plasma. Thromb Res 1983; 31: 427-436

MissingFormLabel
Crossref PubMed Search in Google Scholar